Evidence map›Paper›PMID 37106236›Full record

ReviewTherapeutic innovation & regulatory science2023

Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System.

Binaya Sapkota, Subish Palaian, Sunil Shrestha, Mohamed Izham Mohamed Ibrahim

Open access · hybridAbstract readReview
In one paragraph

Review in Therapeutic innovation & regulatory science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Binaya SapkotaFaculty of Health Sciences, Nobel College, Sinamangal, Kathmandu, Nepal. binaya@nobelcollege.edu.np.ORCID 0000-0002-4125-9866
Subish PalaianDepartment of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.ORCID 0000-0002-9323-3940
Sunil ShresthaSchool of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500, Sunway, Selangor, Malaysia.ORCID 0000-0002-9174-7120
Mohamed Izham Mohamed IbrahimCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.ORCID 0000-0001-9757-3574
Ajman University · AEMonash University Malaysia · MYNobel Academy · NPQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materiovigilance (Mv) has the same purpose and approach in ensuring patient safety as pharmacovigilance but deals with medical devices associated with adverse events (MDAEs) and their monitoring. Mv has been instrumental in recalling many defective or malfunctioning devices based on their safety data. All MDAEs, such as critical or non-critical, known, or unknown, those with inadequate or incomplete specifications, and frequent or rare events should be reported and evaluated. Mv helps to improve medical devices' design and efficiency profile and avoid device-related complications and associated failures. It alerts consumers and health professionals regarding counterfeit or substandard devices. Common events reported through Mv are device breakage and malfunction, entry- and exit-site infections, organ perforations or injuries, need for surgery and even death, and life cycle assessment of devices. Health authorities globally have developed reporting frameworks with timeframes for MDAEs, such as MedWatch in the USA, MedSafe in New Zealand, and others. Health professionals and consumers need to be made aware of the significance of Mv in ensuring the safe use of medical devices and getting familiar with the reporting procedures and action plans in case of a device-induced adverse event.

Indexed as

Health PersonnelPharmacovigilanceDelivery of Health CareHumansPatient SafetyDevice recallMateriovigilanceMedical devicesMedical devices associated adverse events (MDAEs)PharmacovigilanceRegulationReporting guidelines

Identifiers

PMID37106236
PMCPMC10139667
OpenAlexW4367173635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.